Q4 2025 Holdings
Filed 2026-02-13 | 94 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $47.4M | 61,400 | 4.4% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $45.4M | 42,220 | 4.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $41.1M | 431,207 | 3.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $28.4M | 296,000 | 2.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $27.2M | 48,000 | 2.5% |
| Cooper COS Inc(COO) | COM | 216648501 | $26.8M | 327,500 | 2.5% |
| CVS Health Corp(CVS) | COM | 126650100 | $26.6M | 335,500 | 2.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $25.3M | 110,575 | 2.4% |
| Glaukos Corp(GKOS) | COM | 377322102 | $23.7M | 210,000 | 2.2% |
| Danaher Corporation(DHR) | COM | 235851102 | $22.7M | 99,052 | 2.1% |
| Cencora Inc(COR) | COM | 03073E105 | $21.4M | 63,375 | 2.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $21.3M | 420,000 | 2.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $21.0M | 25,600 | 2.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $21.0M | 114,800 | 2.0% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $19.9M | 1,009,450 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $19.8M | 113,585 | 1.8% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $19.5M | 33,640 | 1.8% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $19.2M | 611,000 | 1.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $18.2M | 45,675 | 1.7% |
| United Health Group Inc(UNH) | COM | 91324P102 | $18.1M | 54,900 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $17.8M | 125,491 | 1.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $17.3M | 61,000 | 1.6% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $16.5M | 372,750 | 1.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $16.5M | 193,500 | 1.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $16.4M | 163,350 | 1.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $16.3M | 92,350 | 1.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $15.5M | 34,255 | 1.5% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $15.5M | 146,263 | 1.5% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $15.5M | 126,150 | 1.4% |
| Align Technology Inc(ALGN) | COM | 016255101 | $15.5M | 99,000 | 1.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $15.2M | 76,504 | 1.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.8M | 215,000 | 1.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $12.6M | 74,030 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $12.5M | 158,500 | 1.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $11.8M | 36,000 | 1.1% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $11.7M | 190,000 | 1.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $11.4M | 19,550 | 1.1% |
| The Cigna Group(CI) | COM | 125523100 | $10.6M | 38,650 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $10.3M | 147,600 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.2M | 487,000 | 1.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $10.2M | 537,500 | 1.0% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $10.1M | 357,346 | 0.9% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $9.8M | 605,000 | 0.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $9.8M | 31,500 | 0.9% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $9.6M | 144,500 | 0.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.4M | 374,450 | 0.9% |
| Natera Inc(NTRA) | COM | 632307104 | $9.3M | 40,500 | 0.9% |
| Kura Oncology in(KURA) | COM | 50127T109 | $9.1M | 872,000 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.7M | 133,500 | 0.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.6M | 250,000 | 0.8% |